In vivo (1)H MRSI of glycine in brain tumors at 3T.
In vivo (1)H MRSI of glycine in brain tumors at 3T.
复制标题
DOI:
10.1002/mrm.25588
复制
发表时间:
2016-01
影响因子:
3.3
通讯作者:
Choi C
中科院分区:
文献类型:
--
作者:
Ganji SK;Maher EA;Choi C
MR spectroscopic imaging of glycine (Gly) in the human brain is challenging due to the interference of the abundant neighboring J-coupled resonances. We aim to accomplish reliable imaging of Gly in healthy brain and brain tumors using an optimized MR sequence scheme at 3T. Two dimensional 1H spectroscopic imaging (SI) was performed with a point-resolved spectroscopy (PRESS) scheme. An echo time of 160 ms was used for separation between Gly and myo-inositol (mIns) signals. Data were collected from eight healthy volunteers and fourteen subjects with gliomas. Spectra were analyzed, with LCModel, using numerically-calculated basis spectra. Metabolite concentrations were estimated with reference to creatine in white matter regions at 6.4 mM. From a linear regression analysis with respect to the fractional gray matter content, the Gly concentrations in pure gray and white matter in healthy brain were estimated to be 1.1 and 0.3 mM, respectively. Gly was significantly elevated in tumors. The tumor-to-contralateral Gly concentration ratio was more extensive with higher grades, showing ~10 fold elevation of Gly in glioblastomas. The Gly level is significantly different between gray and white matter in healthy brain. Our data indicate that spectroscopic imaging of Gly may provide a biomarker of brain tumor malignancy.